Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rat hepatitis E virus infection has multiphasic viral replication kinetics <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

A robust cell-based infection model for Rhinovirus C research and antiviral drug discovery.

Npj viruses·2026
Same author

4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.

Biochemical pharmacology·2026
Same author

Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection.

eGastroenterology·2026
Same author

A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication.

Viruses·2026
Same author

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains.

Vaccines·2026

Related Experiment Video

Updated: Jun 23, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

A rat model for hepatitis E virus.

Yannick Debing1, Niraj Mishra1, Erik Verbeken2

  • 1Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven 3000, Belgium.

Disease Models & Mechanisms
|August 3, 2016
PubMed
Summary
This summary is machine-generated.

A new rat model using the Hepatitis E virus (HEV) strain LA-B350 in athymic nude rats aids in developing antiviral therapies for Hepatitis E infection. This model shows promise for testing drugs like ribavirin against HEV.

Keywords:
Animal modelAntiviralHepatitis E virusLA-B350RatRibavirin

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

8.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Related Experiment Videos

Last Updated: Jun 23, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

8.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Area of Science:

  • Virology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis E virus (HEV) causes acute viral hepatitis, with chronic HEV posing challenges in transplant recipients.
  • Limited understanding of HEV replication and few therapeutic options hinder treatment development.
  • A lack of suitable animal models impedes research into HEV therapies.

Purpose of the Study:

  • To establish and validate a novel animal model for studying HEV replication and antiviral efficacy.
  • To investigate the susceptibility of rat HEV to known antiviral agents.
  • To demonstrate the potential for 'humanizing' the rat HEV strain for broader research applications.

Main Methods:

  • Construction and infectivity testing of a cDNA clone (pLA-B350) and a subgenomic replicon (pLA-B350/luc) of rat HEV strain LA-B350.
  • In vitro and in vivo assessment of antiviral activity of interferon, ribavirin, and mycophenolic acid against rat HEV.
  • Generation of a chimeric replicon by swapping HEV polymerase sequences to assess 'humanization' potential.
  • In vivo efficacy study of ribavirin in athymic nude rats infected with rat HEV.

Main Results:

  • The rat HEV strain LA-B350 was successfully established in athymic nude rats, with validated in vitro and in vivo infectivity.
  • Rat HEV showed reduced sensitivity to interferon, ribavirin, and mycophenolic acid compared to human HEV genotype 3.
  • A chimeric replicon demonstrated successful 'humanization', indicating the LA-B350 strain's adaptability.
  • Ribavirin effectively inhibited rat HEV replication in the established athymic nude rat model.

Conclusions:

  • Athymic nude rats infected with rat HEV LA-B350 provide a robust and convenient animal model for HEV research.
  • The model is suitable for in vitro and in vivo antiviral drug screening and development.
  • The rat HEV strain's amenability to 'humanization' opens avenues for studying human-relevant HEV biology and therapies.